Katherine A. Eade - Net Worth and Insider Trading
Katherine A. Eade Net Worth
The estimated net worth of Katherine A. Eade is at least $421,049 dollars as of 2024-05-15. Katherine A. Eade is the Director of Harvard Bioscience Inc and owns about 121,515 shares of Harvard Bioscience Inc (HBIO) stock worth over $421,049. Details can be seen in Katherine A. Eade's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Katherine A. Eade has not made any transactions after 2019-08-09 and currently still holds the listed stock(s).
Transaction Summary of Katherine A. Eade
Katherine A. Eade Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Katherine A. Eade owns 2 companies in total, including Harvard Bioscience Inc (HBIO) , and Vaxxinity Inc (VAXX) .
Click here to see the complete history of Katherine A. Eade’s form 4 insider trades.
Insider Ownership Summary of Katherine A. Eade
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HBIO | Harvard Bioscience Inc | 2021-01-04 | director |
| VAXX | Vaxxinity Inc | 2023-02-01 | director |
Katherine A. Eade Latest Holdings Summary
Katherine A. Eade currently owns a total of 1 stock. Katherine A. Eade owns 121,515 shares of Harvard Bioscience Inc (HBIO) as of August 9, 2019, with a value of $421,049.
Latest Holdings of Katherine A. Eade
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HBIO | Harvard Bioscience Inc | 2019-08-09 | 121,515 | 3.47 | 421,049 |
Holding Weightings of Katherine A. Eade
Katherine A. Eade Form 4 Trading Tracker
According to the SEC Form 4 filings, Katherine A. Eade has made a total of 1 transactions in Harvard Bioscience Inc (HBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Harvard Bioscience Inc is the acquisition of 39,915 shares on August 9, 2019, which cost Katherine A. Eade around $98,989.
Insider Trading History of Katherine A. Eade
- 1
Katherine A. Eade Trading Performance
GuruFocus tracks the stock performance after each of Katherine A. Eade's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Katherine A. Eade is 10.48%. GuruFocus also compares Katherine A. Eade's trading performance to market benchmark return within the same time period. The performance of stocks bought by Katherine A. Eade within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Katherine A. Eade's insider trading performs compared to the benchmark.
Performance of Katherine A. Eade
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.89 | | | | | |
| Relative Return to S&P 500(%) | 8.84 | | | | | |
Katherine A. Eade Ownership Network
Katherine A. Eade Owned Company Details
What does Harvard Bioscience Inc do?
Who are the key executives at Harvard Bioscience Inc?
Katherine A. Eade is the director of Harvard Bioscience Inc. Other key executives at Harvard Bioscience Inc include director & Chief Executive Officer James W Green , Interim CFO Jennifer Cote , and Chief Financial Officer Michael A. Rossi .
Harvard Bioscience Inc (HBIO) Insider Trades Summary
Over the past 18 months, Katherine A. Eade made no insider transaction in Harvard Bioscience Inc (HBIO). Other recent insider transactions involving Harvard Bioscience Inc (HBIO) include a net purchase of 95,000 shares made by James W Green , and a net purchase of 30,000 shares made by Alan I Edrick .
In summary, during the past 3 months, insiders sold 0 shares of Harvard Bioscience Inc (HBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harvard Bioscience Inc (HBIO) were sold and 125,000 shares were bought by its insiders, resulting in a net purchase of 125,000 shares.
Harvard Bioscience Inc (HBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Harvard Bioscience Inc Insider Transactions
Katherine A. Eade Mailing Address
Above is the net worth, insider trading, and ownership report for Katherine A. Eade. You might contact Katherine A. Eade via mailing address: C/o Harvard Bioscience, Inc., 84 October Hill Road #10, Holliston Ma 01746.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
